Activation of NF-kappa B by XIAP, the X chromosome-linked inhibitor of apoptosis, in endothelial cells involves TAK1
about
IAP suppression of apoptosis involves distinct mechanisms: the TAK1/JNK1 signaling cascade and caspase inhibition.Notch inhibits apoptosis by direct interference with XIAP ubiquitination and degradationXIAP: cell death regulation meets copper homeostasisThe gene product Murr1 restricts HIV-1 replication in resting CD4+ lymphocytesA novel role for XIAP in copper homeostasis through regulation of MURR1VIAF, a conserved inhibitor of apoptosis (IAP)-interacting factor that modulates caspase activationGIDE is a mitochondrial E3 ubiquitin ligase that induces apoptosis and slows growthIEX-1: a new ERK substrate involved in both ERK survival activity and ERK activationXIAP deficiency: a unique primary immunodeficiency best classified as X-linked familial hemophagocytic lymphohistiocytosis and not as X-linked lymphoproliferative diseaseTwo discrete events, human T-cell leukemia virus type I Tax oncoprotein expression and a separate stress stimulus, are required for induction of apoptosis in T-cellsTargeting Cell Survival Proteins for Cancer Cell DeathSmall-molecule SMAC mimetics as new cancer therapeuticsXIAP regulates cytosol-specific innate immunity to Listeria infectionContribution of caspase(s) to the cell cycle regulation at mitotic phaseXIAP Induces NF-κB Activation via the BIR1/TAB1 Interaction and BIR1 DimerizationDiscovery of a Potent Small-Molecule Antagonist of Inhibitor of Apoptosis (IAP) Proteins and Clinical Candidate for the Treatment of Cancer (GDC-0152)ILPIP, a novel anti-apoptotic protein that enhances XIAP-mediated activation of JNK1 and protection against apoptosisDoes antigen masking by ubiquitin chains protect from the development of autoimmune diseases?Involvement of transforming growth factor alpha in the regulation of rat ovarian X-linked inhibitor of apoptosis protein expression and follicular growth by follicle-stimulating hormoneX-linked inhibitor of apoptosis (XIAP) inhibits c-Jun N-terminal kinase 1 (JNK1) activation by transforming growth factor beta1 (TGF-beta1) through ubiquitin-mediated proteosomal degradation of the TGF-beta1-activated kinase 1 (TAK1)Inflammation, endothelial injury, and persistent pulmonary hypertension in heterozygous BMPR2-mutant miceA role for NRAGE in NF-kappaB activation through the non-canonical BMP pathway.IAP regulation of metastasis.Overcoming chemotherapy drug resistance by targeting inhibitors of apoptosis proteins (IAPs)A small peptide modeled after the NRAGE repeat domain inhibits XIAP-TAB1-TAK1 signaling for NF-κB activation and apoptosis in P19 cells.Activation of RhoA-ROCK-BMP signaling reprograms adult human corneal endothelial cells.Validation and application of a liquid chromatography-tandem mass spectrometric method for the determination of GDC-0152 in human plasma using solid-phase extraction.African swine fever virus IAP-like protein induces the activation of nuclear factor kappa BThe inositol phosphatase SHIP-1 inhibits NOD2-induced NF-κB activation by disturbing the interaction of XIAP with RIP2.Cadmium down-regulates expression of XIAP at the post-transcriptional level in prostate cancer cells through an NF-kappaB-independent, proteasome-mediated mechanism.In vivo gene delivery of XIAP protects against myocardial apoptosis and infarction following ischemia/reperfusion in conscious rabbits.Apoptosis-inducing factor: structure, function, and redox regulation.Suppression of PTEN expression by NF-kappa B prevents apoptosis.Transcriptome sequencing reveals potential mechanism of cryptic 3' splice site selection in SF3B1-mutated cancersThe X-linked inhibitor of apoptosis protein (XIAP) is up-regulated in metastatic melanoma, and XIAP cleavage by Phenoxodiol is associated with Carboplatin sensitization.Nondegradative ubiquitination of apoptosis inducing factor (AIF) by X-linked inhibitor of apoptosis at a residue critical for AIF-mediated chromatin degradationAdult neuron survival strategies--slamming on the brakes.Inhibitor of apoptosis proteins: new therapeutic targets in hematological cancer?Preclinical Assessment of Mutant Human TRIM5α as an Anti-HIV-1 TransgeneReawakening the cellular death program in neoplasia through the therapeutic blockade of IAP function.
P2860
Q24292370-E5B24469-2026-4894-ADED-F59244255D84Q24298097-C50AC34F-08EF-4746-B846-0DAC15401E1AQ24300814-74813C7F-72DE-4820-BC4A-533ADD3530D4Q24302212-6964AD59-675D-47A4-A689-94C3612E2F8EQ24302274-8E0C4082-FB31-4AC2-9A75-8EE13ECFC83AQ24304221-F224286E-179E-4E48-B8EA-15E9CB6D947FQ24308802-1B9B7D29-65F3-4288-A4F0-87568DD14D4FQ24534869-F7D09B73-69E0-45F3-8B86-071D7BF70E75Q24610800-DA09178B-D1B3-4698-B288-0B647EB9CA23Q24804943-CD52C76A-2AD9-4131-974D-AD83F37D120CQ26765447-85B6C7E3-90A3-402F-8CD9-7A850EED28CDQ26864204-72920A38-5CA1-458C-B21A-0166A7903294Q27318530-23C0B8A7-C796-42D2-89E3-361FC83271A7Q27348581-85DA8883-AEF3-4361-9499-BC50993E25F7Q27645534-9DD9A62E-54F9-40A4-9A81-695EAB3FCD2AQ27678027-F9655A21-7FB0-430C-B819-97CE30EB540FQ28202543-AA5BB915-EA76-4E6A-AB91-4AD8A3A46D8CQ28387136-6349B42B-E14C-4C48-8FF5-34811A91CDABQ28564238-07CBF028-D270-4A75-AC5A-B9ACB06CF108Q28584353-FD319CFF-109F-4DDC-8FFE-88F91A86CC52Q28590362-07131C51-0AAB-4A5E-A38A-902B0DCA69F2Q33526462-0C5C0274-BD58-41A5-886F-5D55B786406BQ33638504-14C02E07-AA68-4A45-A750-E91745E55F7AQ33841579-82F8A8C6-B431-4C5D-AF50-8AFBE7E0D79BQ33971047-9C8A2440-2752-498A-AA76-BE3DBA71324EQ34185807-0B4768D8-6F1C-4E5C-9048-B5D8145A196BQ34279510-6E9083F7-C353-427F-A29B-2E11362AAEABQ34336439-EC25F983-0EF0-48BE-B8CE-5029A6EBC92EQ34345519-1747E35C-2D25-4D8B-A225-40B1A3051BA1Q34602140-70828F29-2910-4754-8D78-E5ECF06A351BQ34717828-F9AF37FB-E32E-4BCA-A140-341287B879D6Q34987223-F410BAED-B8A9-4E1E-B846-B77761ABF889Q35544303-CFA3024F-DB26-4CAE-A5F2-681E95FECB6CQ35577014-6FF8F77A-B10C-4BB6-83B9-BCABEA95D400Q35632517-D4FB4D45-6805-49BE-86C3-1F41BBE15509Q35770711-3B9B0703-6E25-4C32-93F3-1BBA1EDC7191Q35868063-84E8CC07-4E33-4827-BE3C-4E3FEA7AF1CFQ35905166-5FD4FE3E-BDBA-437D-839B-1B6474423691Q36242630-AAB6DAA9-979C-40D3-ABEF-9DE0E8D5D87AQ36274969-5101760F-81CE-4DFA-96B3-9BA8E52B534A
P2860
Activation of NF-kappa B by XIAP, the X chromosome-linked inhibitor of apoptosis, in endothelial cells involves TAK1
description
2000 nî lūn-bûn
@nan
2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Activation of NF-kappa B by XI ...... ndothelial cells involves TAK1
@ast
Activation of NF-kappa B by XI ...... ndothelial cells involves TAK1
@en
Activation of NF-kappa B by XI ...... ndothelial cells involves TAK1
@nl
type
label
Activation of NF-kappa B by XI ...... ndothelial cells involves TAK1
@ast
Activation of NF-kappa B by XI ...... ndothelial cells involves TAK1
@en
Activation of NF-kappa B by XI ...... ndothelial cells involves TAK1
@nl
prefLabel
Activation of NF-kappa B by XI ...... ndothelial cells involves TAK1
@ast
Activation of NF-kappa B by XI ...... ndothelial cells involves TAK1
@en
Activation of NF-kappa B by XI ...... ndothelial cells involves TAK1
@nl
P2093
P921
P356
P1476
Activation of NF-kappa B by XI ...... ndothelial cells involves TAK1
@en
P2093
Hofer-Warbinek R
de Martin R
P304
22064-22068
P356
10.1074/JBC.M910346199
P407
P577
2000-07-01T00:00:00Z